Economic evaluation and cost of interventions for cerebral palsy: a systematic review
Aim Economic appraisal can help guide policy‐making for purchasing decisions, and
treatment and management algorithms for health interventions. We conducted a systematic …
treatment and management algorithms for health interventions. We conducted a systematic …
The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia
N Danchenko, KM Johnston… - Journal of Medical …, 2022 - Taylor & Francis
Objective To evaluate the costs and benefits associated with the use of abobotulinumtoxinA
(aboBoNT-A) and onabotulinumtoxinA (onaBoNT-A) for lower limb spasticity in children …
(aboBoNT-A) and onabotulinumtoxinA (onaBoNT-A) for lower limb spasticity in children …
[HTML][HTML] A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus
E Gerard, A Balbert, G Bavikatte… - Journal of …, 2021 - ncbi.nlm.nih.gov
This consensus paper is derived from a meeting of an international group of 19 neurological
rehabilitation specialists with a combined experience of more than 250 years (range 4–25 …
rehabilitation specialists with a combined experience of more than 250 years (range 4–25 …
经筋刺法对痉挛型脑性瘫痪患者下肢痉挛状态的影响
赵勇， 金炳旭， 刘振寰 - 上海针灸杂志, 2016 - cqvip.com
目的观察经筋刺法治疗痉挛型脑性瘫痪患者下肢痉挛的临床疗效. 方法将80
例痉挛型脑性瘫痪患者随机分为治疗组和对照组, 每组40 例. 两组均采用常规康复治疗 …
例痉挛型脑性瘫痪患者随机分为治疗组和对照组, 每组40 例. 两组均采用常规康复治疗 …
Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada
K Johnston, N Danchenko, R Hansen… - Journal of Medical …, 2020 - Taylor & Francis
Background: Injectable botulinum neurotoxins are a mainstay of treatment for pediatric
spasticity. AbobotulinumtoxinA and onabotulinumtoxinA are both injectable toxin therapies …
spasticity. AbobotulinumtoxinA and onabotulinumtoxinA are both injectable toxin therapies …
[HTML][HTML] Descriptive analysis of the annual cost of treating spasticity with different types of botulinum toxin A
DH Herrero, JCM Page - Neurología (English Edition), 2022 - Elsevier
Introduction Botulinum toxin A is the first-line treatment for localised spasticity. However, the
economic impact of this treatment is not fully known. This study aimed to describe the real …
economic impact of this treatment is not fully known. This study aimed to describe the real …
[HTML][HTML] Efectividad de la toxina botulínica tipo A en el tratamiento de niños con parálisis cerebral infantil
Y Figueroa Ferrer, HR Alvarez Luna… - Acta Médica del …, 2022 - scielo.sld.cu
Introducción: la parálisis cerebral infantil es la causa más frecuente de discapacidad motora
durante la niñez. La toxina botulínica tipo A es considerada una de las principales opciones …
durante la niñez. La toxina botulínica tipo A es considerada una de las principales opciones …
Beneficios de toxina botulínica en el tratamiento fisioterapéutico de la parálisis cerebral infantil
RB Karla Micaela - 2021 - dspace.unach.edu.ec
La investigación se enfocó en la modalidad de revisión bibliográfica, dando a conocer los
beneficios de toxina botulínica en el tratamiento fisioterapéutico de la parálisis cerebral …
beneficios de toxina botulínica en el tratamiento fisioterapéutico de la parálisis cerebral …
Cost analysis of botulinum therapy of spastic forms of cerebral palsy in Ukraine
SO Soloviov, OV Nazar, MV Leleka - Farmatsevtychnyi zhurnal, 2021 - pharmj.org.ua
Cerebral palsy (CP) represents a group of disorders of the mechanisms of movement and
body position, causing limitations of activity, which are caused by non-progressive damage …
body position, causing limitations of activity, which are caused by non-progressive damage …
[HTML][HTML] Análisis descriptivo de coste de tratamiento de la espasticidad con diferentes tipos de toxina botulínica A, a lo largo de un año
DH Herrero, JCM Page - Neurología, 2022 - Elsevier
Introducción La toxina botulínica A es el tratamiento de elección para la espasticidad
localizada. Sin embargo, no se tiene un conocimiento real de su repercusión económica. El …
localizada. Sin embargo, no se tiene un conocimiento real de su repercusión económica. El …